Daily News Podcast

Daily News Special: SABCS

Publish date: January 12, 2019

 

In this special edition of the MDedge Daily News, Nick Andrews and Terry Rudd report the latest news from the 2018 San Antonio Breast Cancer Symposium. Stories include: uUing low-dose tamoxifen, the latest findings from the KATHERINE trial, results of a meta-analysis of neoadjuvant chemotherapy, and capecitabine in early stage triple negative breast cancer.

Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

Recommended Reading

Oxybutynin rapidly quells hot flashes
MDedge Hematology and Oncology
Extended AI therapy reduces breast cancer recurrence risk, ups fracture risk
MDedge Hematology and Oncology
Data underscore the importance of lifestyle interventions in breast cancer patients
MDedge Hematology and Oncology
QOL is poorer for young women after mastectomy than BCS
MDedge Hematology and Oncology
Survivors of childhood Hodgkin lymphoma face 14-fold risk of second cancers
MDedge Hematology and Oncology
Older breast cancer patients given adjuvant chemo live longer
MDedge Hematology and Oncology
Young women opt for mastectomy even when neoadjuvant chemo works well
MDedge Hematology and Oncology
Poor-prognosis cancers linked to highest suicide risk in first year
MDedge Hematology and Oncology
Actionable mutations more likely in women with both breast and uterine cancer
MDedge Hematology and Oncology
Neoadjuvant degarelix more effective than triptorelin for ovarian suppression
MDedge Hematology and Oncology